Saraswati Sukumar

14PUBLICATIONS
93CO-AUTHORS
Metabolomic chemistryPredictive and prognostic markersNanomaterialsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 23, 2026
Development of the cf-MMSP Assay for Enhanced Analytical Sensitivity of Methylated DNA in Breast Cancer Liquid Biopsy.

|Jan 01, 2025
Evaluating DNA Methylation in Random Fine Needle Aspirates from the Breast to Inform Cancer Risk.

Kala Visvanathan, Ashley Cimino-Mathews, Mary Jo Fackler

|Apr 20, 2024
Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.

Mary Jo Fackler, Madison Pleas, Youran Li

|Jun 16, 2023
Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer.

Bozhao Li, Feilong Qi, Fei Zhu

|Dec 19, 2022
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial.

Kala Visvanathan, Leslie Cope, Mary Jo Fackler

|Sep 27, 2022
HOXA5-Mediated Stabilization of IκBα Inhibits the NF-κB Pathway and Suppresses Malignant Transformation of Breast Epithelial Cells.

Priya Pai, Guannan Wang, Wei Wen Teo

Pageof 3

Frequent Collaborators

4 joint publications

Mary Jo Fackler

3 joint publications

Guannan Wang

2 joint publications

Antonio C Wolff

2 joint publications

Preethi Korangath